Globally, smoking was the biggest risk factor for men, accounting for almost one-quarter of the 4.3 million preventable ...
Boston Scientific’s share price — which medical device competitors have long envied — sputtered Feb. 4 after the company ...
Boston Scientific (BSX), a leading global player in medical devices, announced solid Q4 earnings but offered 2026 guidance ...
Boston Scientific stock fell 8.4% despite beating Q4 earnings as weak Q1 guidance and electrophysiology division miss ...
On Wednesday, Boston Scientific experienced a loss of nearly one-fifth of its market capitalization in a single trading ...
Boston Scientific Corporation (NYSE:BSX) is included among 13 Best Long Term Low Risk Stocks to Buy Now. On February 5, Truist lowered its price objective on Boston Scientific Corporation (NYSE:BSX) ...
Today, Feb. 4, 2026, investors are weighing Boston Scientific’s guidance against new deals and its long-term margin path.
By Kamal Choudhury Feb 4 (Reuters) - Boston Scientific on Wednesday reported lower-than-expected quarterly sales in its key electrophysiology division, dragging the medical device maker's shares as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results